Brief: Uspto Grants New Patent To Evoke Pharma Covering Usage Of Gimoti® To Treat Moderate To Severe Gastroparesis
07/12/2022 13:43
Evoke Pharma Inc EVOK.O :
* USPTO GRANTS NEW PATENT TO EVOKE PHARMA COVERING USAGE OF
GIMOTI® TO TREAT MODERATE TO SEVERE GASTROPARESIS
* EVOKE PHARMA INC - PATENT EXPIRES IN 2038
Source text for Eikon: ID:nGNX4QrvhL
Further company coverage: EVOK.O
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary